Dolores V. Dougherty

527 total citations
17 papers, 444 citations indexed

About

Dolores V. Dougherty is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Dolores V. Dougherty has authored 17 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Dolores V. Dougherty's work include Glioma Diagnosis and Treatment (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroblastoma Research and Treatments (3 papers). Dolores V. Dougherty is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroblastoma Research and Treatments (3 papers). Dolores V. Dougherty collaborates with scholars based in United States, Canada and China. Dolores V. Dougherty's co-authors include Mark L. Rosenblum, Jane R. Giblin, J. R. McCulloch, James T. Rutka, Charles B. Wilson, Massimo Gerosa, S. J. DeArmond, Michael E. Berens, François Doz and C. B. Wilson and has published in prestigious journals such as Cancer, Journal of neurosurgery and Neurosurgery.

In The Last Decade

Dolores V. Dougherty

17 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dolores V. Dougherty United States 11 176 125 114 65 54 17 444
Edwige Voisset France 10 252 1.4× 82 0.7× 106 0.9× 109 1.7× 44 0.8× 16 594
Cornelia Grimmel Germany 12 556 3.2× 90 0.7× 161 1.4× 56 0.9× 39 0.7× 16 777
Yuho Hayashi United States 9 469 2.7× 106 0.8× 174 1.5× 38 0.6× 69 1.3× 10 734
Susan Jones‐Bolin United States 9 424 2.4× 185 1.5× 184 1.6× 26 0.4× 26 0.5× 14 769
Anice Moumen France 13 333 1.9× 86 0.7× 79 0.7× 30 0.5× 181 3.4× 15 680
Tércia Alves Brazil 9 246 1.4× 114 0.9× 67 0.6× 17 0.3× 11 0.2× 10 470
George A. Basler United States 10 115 0.7× 158 1.3× 109 1.0× 77 1.2× 38 0.7× 11 373
Joanna S. Remack United States 18 563 3.2× 186 1.5× 148 1.3× 32 0.5× 50 0.9× 21 719
Sarah M. Jacobs-Helber United States 13 391 2.2× 101 0.8× 253 2.2× 20 0.3× 8 0.1× 16 782
BaoHan T. Vo United States 12 335 1.9× 31 0.2× 114 1.0× 77 1.2× 23 0.4× 15 502

Countries citing papers authored by Dolores V. Dougherty

Since Specialization
Citations

This map shows the geographic impact of Dolores V. Dougherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolores V. Dougherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolores V. Dougherty more than expected).

Fields of papers citing papers by Dolores V. Dougherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolores V. Dougherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolores V. Dougherty. The network helps show where Dolores V. Dougherty may publish in the future.

Co-authorship network of co-authors of Dolores V. Dougherty

This figure shows the co-authorship network connecting the top 25 collaborators of Dolores V. Dougherty. A scholar is included among the top collaborators of Dolores V. Dougherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolores V. Dougherty. Dolores V. Dougherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Roosen, N., et al.. (1994). Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine. Cancer Chemotherapy and Pharmacology. 34(5). 385–392. 5 indexed citations
2.
Doz, François, Michael E. Berens, Christian F. Deschepper, et al.. (1992). Experimental basis for increasing the therapeutic index ofcis-diamminedicarboxylatocyclobutaneplatinum(II) in brain tumor therapy by a high-zinc diet. Cancer Chemotherapy and Pharmacology. 29(3). 219–226. 3 indexed citations
3.
Doz, François, Michael E. Berens, Dolores V. Dougherty, & Mark L. Rosenblum. (1991). Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. Journal of Neuro-Oncology. 11(1). 27–35. 39 indexed citations
4.
Doz, François, et al.. (1991). Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds. Cancer Chemotherapy and Pharmacology. 28(4). 308–310. 7 indexed citations
5.
Dougherty, Dolores V., et al.. (1990). Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.. PubMed. 103(8). 658–65. 52 indexed citations
6.
Berens, Michael E., Jane R. Giblin, Dolores V. Dougherty, et al.. (1988). Comparison ofin vitroCloning Assays for Drug Sensitivity Testing of Human Brain Tumours. British Journal of Neurosurgery. 2(2). 227–234. 11 indexed citations
7.
Rutka, James T., Jane R. Giblin, Dolores V. Dougherty, et al.. (1988). Partial characterization of a soluble mitogenic factor from medulloblastoma. Journal of neurosurgery. 68(2). 251–258. 2 indexed citations
8.
Rutka, James T., Dolores V. Dougherty, Jane R. Giblin, et al.. (1987). Growth of a Medulloblastoma on Normal Leptomeningeal Cells in Culture: Interaction of Tumor Cells and Normal Cells. Neurosurgery. 21(6). 872–878. 10 indexed citations
9.
Rutka, James T., Jane R. Giblin, Hanne K. Høifødt, et al.. (1986). Establishment and characterization of a cell line from a human gliosarcoma.. PubMed. 46(11). 5893–902. 37 indexed citations
10.
Rutka, James T., Jane R. Giblin, Dolores V. Dougherty, et al.. (1986). An Ultrastructural and Immunocytochemical Analysis of Leptomeningeal and Meningioma Cultures. Journal of Neuropathology & Experimental Neurology. 45(3). 285–303. 85 indexed citations
11.
Rutka, James T., Jane R. Giblin, Dolores V. Dougherty, et al.. (1986). Characterization of normal human brain cultures. Evidence for the outgrowth of leptomeningeal cells.. PubMed. 55(1). 71–85. 39 indexed citations
12.
Kobayashi, Shu̅, Takao Hoshino, Dolores V. Dougherty, & Mark L. Rosenblum. (1984). Variable response to 1,3-bis(2-chloroethyl)-1-nitrosourea of human glioma cells sorted according to DNA content. Journal of Neuro-Oncology. 2(1). 5–11. 2 indexed citations
13.
Rosenblum, Mark L., Massimo Gerosa, C. B. Wilson, et al.. (1983). Stem cell studies of human malignant brain tumors. Journal of neurosurgery. 58(2). 170–176. 69 indexed citations
14.
Gerosa, Massimo, Dolores V. Dougherty, Charles B. Wilson, & Mark L. Rosenblum. (1983). Improved treatment of a brain-tumor model. Journal of neurosurgery. 58(3). 368–373. 11 indexed citations
15.
Rosenblum, Mark L., Massimo Gerosa, Dolores V. Dougherty, & Charles B. Wilson. (1983). Improved treatment of a brain-tumor model. Journal of neurosurgery. 58(2). 177–182. 30 indexed citations
16.
Hoshino, Takao, Kathy D. Knebel, Mark L. Rosenblum, Dolores V. Dougherty, & Charles B. Wilson. (1982). Clonogenicity of multiple populations of human glioma cells in vitro sorted by DNA content. Cancer. 50(5). 997–1002. 26 indexed citations
17.
Rosenblum, Mark L., et al.. (1981). Potentials and possible pitfalls of human stem cell analysis. Cancer Chemotherapy and Pharmacology. 6(3). 227–35. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026